RPS3AP14

Across TCGA pan-cancer cohorts, RPS3AP14 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RPS3AP14 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RPS3AP14 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS3AP14 expression acts as an unfavorable survival marker, although some lineages such as CHOL and MESO show a favorable association.

LIHC, DLBC, and CHOL are the cancer types where RPS3AP14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	III,IV	0.193	0.408	.003	54	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
CHOL	DFS	Median	All	0.706	0.268	.008	18	view →
MESO	DFS	Tertile	All	0.673	0.292	.011	15	view →
STAD	DFS	Tertile	III,IV	0.474	0.662	.008	13	view →
CESC	OS	Median	II,III,IV	0.888	0.681	.006	12	view →
KIRC	DFS	Median	II,III,IV	0.624	0.794	.001	11	view →
LUSC	DFS	Median	III,IV	0.535	0.758	.014	11	view →
READ	OS	Median	II,III,IV	1.000	0.807	.004	11	view →
BLCA	OS	Tertile	IV	0.142	0.349	.011	9	view →
PCPG	DFS	Quartile	All	0.860	0.981	.021	6	view →
UCEC	OS	Quartile	III,IV	0.735	0.840	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RPS3AP14–LIHC (DFS)

Open the LIHC breakdown →